Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 22, 2023
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
Tue, March 21, 2023
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
[ Tue, Mar 21st 2023
] - WOPRAI
William Pickering Initiated (ARWR) at Hold and Held Target at $27 on, Mar 21st, 2023
William Pickering of Bernstein, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold and Held Target at $27 on, Mar 21st, 2023.
William has made no other calls on ARWR in the last 4 months.
There are 9 other peers that have a rating on ARWR. Out of the 9 peers that are also analyzing ARWR, 2 agree with William's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $31 on, Tuesday, November 29th, 2022
- Andrew Galler of "Morgan Stanley" Maintained at Hold with Decreased Target to $37 on, Tuesday, November 29th, 2022
These are the ratings of the 7 analyists that currently disagree with William
- Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $60 on, Friday, February 10th, 2023
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Friday, February 10th, 2023
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, February 8th, 2023
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $52 on, Tuesday, February 7th, 2023
- Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $58 on, Tuesday, February 7th, 2023
- Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $77 on, Tuesday, February 7th, 2023
- Maury Raycroft of "Jefferies" Maintained at Strong Buy with Decreased Target to $75 on, Tuesday, November 29th, 2022
